Prostate Cancer - Results from #1040

REVIEW UroToday

Beyond the Abstract - CD10 is inversely associated with nuclear factor-kappa B and predicts biochemical recurrence after radical prostatectomy, by Panagiotis J. Vlachostergios, George Moutzouris, and Christos N. Papandreou July 9, 2012

Beyond the Abstract - Rubin H. Flocks and colloidal gold treatments for prostate cancer, by Charles E. Hawtrey, MD and Michael O'Donnell, MD June 26, 2012

Beyond the Abstract - Long-term outcomes of open radical retropubic prostatectomy for clinically localized prostate cancer in the prostate-specific antigen era, by Ryan Dorin, MD June 20, 2012

Beyond the Abstract - Machine learning for improved pathological staging of prostate cancer: A performance comparison on a range of classifiers, by Olivier Regnier-Coudert, et al June 15, 2012

Beyond the Abstract - Lipid nanoparticle siRNA systems for silencing the androgen receptor in human prostate cancer in vivo, by Justin B. Lee, PhD candidate June 13, 2012

Beyond the Abstract - High-risk prostate cancer: Value of multi-modality 3T MRI-guided biopsies after previous negative biopsies, by Sadhna Verma, MD, et al June 7, 2012

Beyond the Abstract - Impact of androgen deprivation on the lipid profile and atherogenic risk in prostate cancer patients, by C. Salvador Lacambra May 15, 2012

Beyond the Abstract - Postoperative radiotherapy in prostate cancer: The case of the missing target, by Jennifer Croke, MD and Shawn Malone, MD, FRCPC May 10, 2012

Beyond the Abstract - Usefulness and predictive value of PSA density, adjusted by transition zone volume, in men with PSA levels between 2 and 4 ng/ml, by Prof. Abdelatif Janane, MD May 8, 2012

Beyond the Abstract - Blood loss during radical prostatectomy: Impact on clinical, oncological and functional outcomes and complication rates, by Bob Djavan, MD, PhD April 6, 2012

Beyond the Abstract - PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications, by Deloar Hossain, MD March 30, 2012

Beyond the Abstract - Prevalence and correlates of vitamin and supplement usage among men with a family history of prostate cancer, by Christina M. Bauer, Miriam B. Ishak and Kathleen A. Cooney February 15, 2012

Beyond the Abstract - Selective detection of histologically aggressive prostate cancer: An Early Detection Research Network Prediction model to reduce unnecessary prostate biopsies with validation in the Prostate Cancer Prevention Trial February 14, 2012

Beyond the Abstract - Bisphosphonate anticancer activity in prostate cancer and other genitourinary cancers, by Fred Saad, MD February 13, 2012

Beyond the Abstract - Impact of androgen deprivation therapy on depressive symptoms in men with nonmetastatic prostate cancer, by Narhari Timilshina, MPH and Shabbir Alibhai, MD, MSc February 7, 2012

Beyond the Abstract - Palliation and survival after repeated 188Re-HEDP therapy of hormone-refractory bone metastases of prostate cancer: A retrospective analysis, by Hans-Jürgen Biersack, MD February 6, 2012

Beyond the Abstract - A descriptive study of functions, symptoms, and perceived health state after radiotherapy for prostate cancer, by Sheila Cameron, et al January 30, 2012

Beyond the Abstract - Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer, by Chantal Mengus, PhD, et al January 27, 2012

Beyond the Abstract - Optimization of PSA screening policies: A comparison of the patient and societal perspectives, by Jingyu Zhang, PhD January 26, 2012

Beyond the Abstract - A new preoperative nomogram to predict minimal prostate cancer: accuracy and error rates compared to other tools to select patients for active surveillance, by Ronald J. Cohen, MBBCH, FFPATH, FRCPA, PhD January 23, 2012

Page 53 of 57